X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
sportif-iii (51) 51
humans (45) 45
warfarin (34) 34
anticoagulants - therapeutic use (33) 33
stroke - prevention & control (30) 30
atrial fibrillation (27) 27
atrial fibrillation - complications (27) 27
stroke prevention (26) 26
atrial fibrillation - drug therapy (22) 22
ximelagatran (22) 22
index medicus (20) 20
nonvalvular atrial-fibrillation (20) 20
stroke - etiology (20) 20
azetidines - therapeutic use (18) 18
prevention (18) 18
warfarin - therapeutic use (18) 18
venous thromboembolism (17) 17
peripheral vascular disease (16) 16
risk factors (16) 16
stroke (16) 16
cardiac & cardiovascular systems (15) 15
randomized controlled-trial (15) 15
aged (14) 14
anticoagulation (13) 13
antithrombotic therapy (13) 13
direct thrombin inhibitor (13) 13
male (13) 13
treatment outcome (13) 13
anticoagulants (12) 12
clinical neurology (12) 12
female (12) 12
aspirin (11) 11
anticoagulants - adverse effects (10) 10
benzylamines (10) 10
dabigatran (10) 10
medicine, general & internal (10) 10
benzylamines - therapeutic use (9) 9
drug therapy (9) 9
risk (9) 9
follow-up studies (8) 8
oral anticoagulation (8) 8
pyridines - therapeutic use (8) 8
risk assessment (8) 8
trial (8) 8
benzimidazoles - therapeutic use (7) 7
management (7) 7
middle aged (7) 7
randomized controlled trials as topic (7) 7
therapy (7) 7
thrombin - antagonists & inhibitors (7) 7
administration, oral (6) 6
clinical trials (6) 6
dabigatran etexilate (6) 6
double-blind (6) 6
hematology (6) 6
outcomes (6) 6
pharmacology & pharmacy (6) 6
research design (6) 6
risk-factors (6) 6
secondary prevention (6) 6
thrombin inhibitor ximelagatran (6) 6
united states (6) 6
warfarin - adverse effects (6) 6
abridged index medicus (5) 5
anticoagulants - administration & dosage (5) 5
clinical trials as topic (5) 5
double-blind method (5) 5
drugs (5) 5
international normalized ratio (5) 5
knee replacement (5) 5
medical and health sciences (5) 5
medicin och hälsovetenskap (5) 5
myocardial-infarction (5) 5
oral anticoagulant-therapy (5) 5
thromboembolism (5) 5
time factors (5) 5
total knee replacement (5) 5
vitamin k - antagonists & inhibitors (5) 5
adult (4) 4
animals (4) 4
anticoagulants - pharmacology (4) 4
clinical medicine (4) 4
dosage and administration (4) 4
enoxaparin (4) 4
factor xa inhibitors (4) 4
hemorrhage - chemically induced (4) 4
mortality (4) 4
neurosciences (4) 4
stroke - drug therapy (4) 4
stroke - epidemiology (4) 4
thrombosis - prevention & control (4) 4
total hip (4) 4
total hip-replacement (4) 4
aged, 80 and over (3) 3
anti-arrhythmia agents - therapeutic use (3) 3
atrial fibrillation - epidemiology (3) 3
atrial fibrillation - prevention & control (3) 3
atrial-fibrillation (3) 3
azetidines - administration & dosage (3) 3
azetidines - adverse effects (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9689, pp. 534 - 542
Summary Background In patients with non-valvular atrial fibrillation, embolic stroke is thought to be associated with left atrial appendage (LAA) thrombi. We... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | TRANSCATHETER OCCLUSION PLAATO | HIGH-RISK PATIENTS | EVENTS | RHYTHM CONTROL | ANTITHROMBOTIC THERAPY | SPORTIF-III | FOLLOW-UP | ORAL ANTICOAGULANT-THERAPY | OUTCOMES | ASPIRIN | United States - epidemiology | Follow-Up Studies | Humans | Middle Aged | Warfarin - adverse effects | Male | Prosthesis Design | Warfarin - therapeutic use | Cardiac Catheterization | Aged, 80 and over | Adult | Female | Stroke - epidemiology | Atrial Appendage - physiopathology | Embolism - etiology | Safety | Stroke - prevention & control | Prostheses and Implants - adverse effects | Risk Factors | Atrial Fibrillation - complications | Kaplan-Meier Estimate | Proportional Hazards Models | Europe - epidemiology | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Stroke - etiology | Atrial Fibrillation - epidemiology | Pericardial Effusion - etiology | Aged | Hemorrhage - chemically induced | Atrial Fibrillation - prevention & control | Stroke (Disease) | Prevention | Cardiovascular system | Complications and side effects | Warfarin | Atrial fibrillation | Surgery | Dosage and administration | Research | Comparative analysis | Health aspects | Risk factors | Intervention | Disease prevention | Clinical trials | Cardiac arrhythmia | Clinical medicine | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
American Heart Journal, ISSN 0002-8703, 2009, Volume 157, Issue 5, pp. 805 - 810.e2
Vitamin K antagonists (VKAs) are effective for stroke prevention in patients with atrial fibrillation (AF) but are difficult to use. Dabigatran etexilate is a... 
Cardiovascular | XIMELAGATRAN | CARDIAC & CARDIOVASCULAR SYSTEMS | DIRECT THROMBIN INHIBITOR | KNEE REPLACEMENT | STROKE PREVENTION | VENOUS THROMBOEMBOLISM | NONRHEUMATIC ATRIAL-FIBRILLATION | NON-INFERIORITY TRIAL | SPORTIF-III | ETEXILATE | TOTAL HIP-REPLACEMENT | Intracranial Thrombosis - complications | Echocardiography, Transesophageal | Prospective Studies | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Pyridines - pharmacokinetics | Dabigatran | Warfarin - administration & dosage | Warfarin - therapeutic use | Dose-Response Relationship, Drug | Benzimidazoles - administration & dosage | Time Factors | Intracranial Thrombosis - drug therapy | Benzimidazoles - therapeutic use | Electric Countershock - methods | Pyridines - therapeutic use | Stroke - prevention & control | Pyridines - administration & dosage | Double-Blind Method | Administration, Oral | Atrial Fibrillation - drug therapy | Atrial Fibrillation - therapy | Risk Factors | Benzimidazoles - pharmacokinetics | Intracranial Thrombosis - blood | Anticoagulants - therapeutic use | Treatment Outcome | Anti-Arrhythmia Agents - therapeutic use | Warfarin - pharmacokinetics | Stroke - blood | Stroke - etiology | Atrial Fibrillation - diagnostic imaging | Aged | Anticoagulants - pharmacokinetics | Research Design | Clinical trials | Thrombin | Warfarin | Comparative analysis | Atrial fibrillation | Anticoagulants | Medical research | Stroke | Drug therapy | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Circulation, ISSN 0009-7322, 11/2010, Volume 122, Issue 22, pp. 2246 - 2253
Journal Article
JAMA, ISSN 0098-7484, 02/2005, Volume 293, Issue 6, pp. 690 - 698
Journal Article
Journal Article
European Heart Journal, ISSN 0195-668X, 11/2009, Volume 30, Issue 21, pp. 2554 - 2555
Journal Article
Journal Article
Journal of the American Heart Association, ISSN 2047-9980, 09/2018, Volume 7, Issue 18, p. e009766
Background-Patients with atrial fibrillation (AF) treatedwith oral anticoagulantsmay be exposed to an increased risk of bleeding events. The... 
Clinical risk scores | Atrial fibrillation | Bleeding risk | XIMELAGATRAN | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | MANAGEMENT | STROKE PREVENTION | INFORMED TREATMENT | GUIDELINES | SPORTIF-III | bleeding risk | EUROPEAN-SOCIETY | atrial fibrillation | WARFARIN | OUTCOMES REGISTRY | clinical risk scores
Journal Article
Stroke, ISSN 0039-2499, 2007, Volume 38, Issue 9, pp. 2459 - 2463
Journal Article
Journal Article